StonvexLoading…
StonvexStonvexStonvexCore line items from CZFS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $9.88M | $9.61M | $8.97M | $8.59M |
Operating Income | $45.24M | $33.88M | $21.57M | $35.49M |
Net Income | $36.57M | $27.82M | $17.81M | $29.06M |
EPS (Diluted) | $7.62 | $5.79 | $3.98 | $7.17 |
Total Assets | $3.06B | $3.03B | $2.98B | $2.33B |
Total Liabilities | $2.73B | $2.73B | $2.70B | $2.13B |
Cash & Equivalents | $34.29M | $42.20M | $52.82M | $26.21M |
Free Cash Flow OCF − CapEx | $35.24M | $31.87M | $23.92M | $31.61M |
Shares Outstanding | 4.80M | 4.80M | 4.48M | 4.06M |